Abstract The coronavirus disease 2019 (COVID‐19) pandemic is caused by a novel
betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), similar …

Dipeptidyl-peptidase IV/CD26 (DPP IV) is a cell-surface protease belonging to the
prolyloligopeptidase family. It selectively removes the N-terminal dipeptide from peptides …

CD26/DPPIV can be considered a moonlighting protein because it is a multifunctional
protein that exerts its different functions depending on cell type and intra-or extracellular …

CD26 has proved interesting in the fields of immunology, endocrinology, cancer biology and
nutrition owing to its ubiquitous and unusual enzyme activity. This dipeptidyl …

Abstract Dipeptidyl peptidase IV (DPP-IV/CD26) is a multifunctional type II transmembrane
serine peptidase. This enzyme contributes to the regulation of various physiological …

The discovery of incretin-based medications represents a major therapeutic advance in the
pharmacological management of type 2 diabetes mellitus (T2DM), as these agents avoid …

The membrane-bound glycoprotein dipeptidyl peptidase IV (DP IV, CD26) is a unique
multifunctional protein, acting as receptor, binding and proteolytic molecule. We have …

DP (dipeptidyl peptidase) IV is the archetypal member of its six-member gene family. Four
members of this family, DPIV, FAP (fibroblast activation protein), DP8 and DP9, have a rare …

Dipeptidyl peptidase IV (DPPIV, EC 3.4. 14.5) is a serine type protease with an important
modulatory activity on a number of chemokines, neuropeptides and peptide hormones. It is …

Inhibition of dipeptidyl peptidase IV (DPP-IV), the main glucagon-like peptide 1 (GLP1)-
degrading enzyme, has been proposed for the treatment of type II diabetes. We expressed …